Jacqueline M Humes

Title: The Innovations of Jacqueline M Humes

Introduction

Jacqueline M Humes is a prominent inventor based in Seattle, WA. She has made significant contributions to the field of biotechnology, particularly in the area of diabetes treatment. With a total of 4 patents to her name, her work has the potential to impact many lives.

Latest Patents

One of her latest patents is titled "Zinsi polypeptide composition stimulating pancreatic islet growth." This invention provides compositions for stimulating an increase in islet proliferation and β-cell mass using an insulin homolog polypeptide. It also includes methods for treating diabetes by stimulating islet proliferation and β-cell mass increases, thereby affecting insulin levels. Another notable patent is for "Adipocyte-specific protein homologs," which relates to polynucleotide and polypeptide molecules for zsig39, a novel member of the family of proteins bearing a collagen-like domain and a globular domain. These polypeptides and polynucleotides are involved in dimerization or oligomerization and may be used in related studies. The invention also includes antibodies to the zsig39 polypeptides.

Career Highlights

Jacqueline M Humes is currently associated with Zymogenetics, Inc., where she continues to innovate and develop new solutions in biotechnology. Her work has garnered attention for its potential applications in medical treatments.

Collaborations

Throughout her career, she has collaborated with notable colleagues, including Hong Ping Ren and Katherine H Sprugel. These collaborations have further enhanced her research and development efforts.

Conclusion

Jacqueline M Humes is a trailblazer in the field of biotechnology, with her innovative patents paving the way for advancements in diabetes treatment. Her contributions are invaluable and continue to inspire future research in the field.